BELLICUM PHARMACEUTICALS INC's ticker is and the CUSIP is 079481404. A total of 33 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $24,014 | +46080.8% | 72,770 | 0.0% | 0.00% | – |
| Q4 2022 | $52 | -99.9% | 72,770 | -0.2% | 0.00% | – |
| Q3 2022 | $87,000 | +1.2% | 72,925 | 0.0% | 0.00% | – |
| Q2 2022 | $86,000 | -45.2% | 72,925 | 0.0% | 0.00% | – |
| Q1 2022 | $157,000 | +45.4% | 72,925 | 0.0% | 0.00% | – |
| Q4 2021 | $108,000 | -51.6% | 72,925 | -4.7% | 0.00% | – |
| Q3 2021 | $223,000 | +15.5% | 76,533 | +30.5% | 0.00% | – |
| Q2 2021 | $193,000 | +63.6% | 58,659 | +86.8% | 0.00% | – |
| Q1 2021 | $118,000 | +7.3% | 31,400 | 0.0% | 0.00% | – |
| Q4 2020 | $110,000 | -62.6% | 31,400 | -30.0% | 0.00% | – |
| Q3 2020 | $294,000 | -11.4% | 44,864 | +0.3% | 0.00% | – |
| Q2 2020 | $332,000 | +74.7% | 44,750 | +8.7% | 0.00% | – |
| Q1 2020 | $190,000 | – | 41,155 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 448,101 | $537,000 | 0.11% |
| Long Focus Capital Management, LLC | 327,692 | $393,000 | 0.04% |
| Boxer Capital, LLC | 56,950 | $68,000 | 0.00% |
| SHUFRO ROSE & CO LLC | 12,941 | $16,000 | 0.00% |
| Baker Brothers Advisors | 249,123 | $299,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 45,057 | $54,000 | 0.00% |
| Orion Capital Management LLC | 500 | $1,000 | 0.00% |
| Parallel Advisors, LLC | 10 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 779 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 10,981 | $13,000 | 0.00% |